LGC enters into drug alliance

Skip to Navigation

Blog Post

  • Published: Sep 17, 2013
  • Author: Jon Evans
  • Channels: Gas Chromatography / Detectors / Laboratory Informatics / Sample Preparation / Proteomics & Genomics / Electrophoresis / HPLC / Ion Chromatography / NMR Knowledge Base / MRI Spectroscopy / Chemometrics & Informatics / Atomic / Infrared Spectroscopy / Base Peak / UV/Vis Spectroscopy / Proteomics / Raman / X-ray Spectrometry

View comments on this post

The British analytical services company LGC has entered into a strategic alliance with TranScrip Partners, a British contract research organization that supports biopharmaceutical product development. The alliance will allow both companies to combine and enhance their offerings to clients, particularly in the areas of anti-infectives and respiratory disease.

'We’re really excited by this development; LGC’s high quality laboratory services and TranScrip’s expertise in drug development strategy, medical writing and regulatory affairs complement each other beautifully,' said David Griffiths, director, pharmaceutical services, at LGC. 'Whilst both companies support all therapeutic areas, we have a combined strength in anti-infectives.'


There are currently no comments on this post.

Comment Form

You have to log in to comment on this post.

Log in using the form at the top of the page or register here.

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Most Viewed

Copyright Information

Interested in separation science? Visit our sister site separationsNOW.com

Copyright © 2018 John Wiley & Sons, Inc. All Rights Reserved